The most severe adverse effects of EPO are related to a significant risk of thrombotic events, particularly in surgical patients.

There has beenÂ concern regarding the potential progression of tumorigenesis in patients with certain forms of cancer, particularly breast cancer, non-small cell lung cancer, head and neck cancer, lymphoid cancer, and cervical cancer.

Researchers reported nausea, vomiting, diarrhea, fatigue, insomnia, peripheral edema, thrombocytopenia, myalgias, arthralgias, rashes, abdominal pain, headache, and paresthesias as common adverse effects experienced by patients undergoing chemotherapy who received epoetin alfa in a multicenter study.